https://seekingalpha.com/article/4661586-cvs-shares-remain-modestly-undervalued-robust-free-cash-flow-technical-strength?source=feed_all_articles
Jan 07, 2024 - CVS Health has strong earnings, valuation, dividend, and free cash flow forecasts. Click here to read why I reiterate my Buy rating on CVS stock.
0
sa:8740656140734110825
0
https://www.zacks.com/commentary/2206306/top-analyst-reports-for-merck-salesforce-philip-morris?cid=CS-ZC-FT-research_daily-2206306
Jan 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
zc:-5960485884744189558
0
https://www.zacks.com/commentary/2206233/3-retail-pharmacy-drugstore-stocks-to-watch-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2206233
Jan 05, 2024 - Zacks Retail-Pharmacies and Drug Stores industry players like CVS, HLF and RADCQ are likely to gain despite reimbursement challenges that are hurting the overall industry health.
zc:-6382110250610471395
0
https://www.zacks.com/stock/news/2205902/here-s-why-cvs-health-cvs-fell-more-than-broader-market?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205902
Jan 04, 2024 - CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session.
zc:4569600645309303755
0
https://www.zacks.com/stock/news/2205591/cvs-health-corporation-cvs-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2205591
Jan 04, 2024 - Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zc:1325038113806540982
0
https://seekingalpha.com/news/4052170-cvs-to-drop-humira-from-certain-formularies-cover-biosimilars-instead?source=feed_sector_healthcare
Jan 03, 2024 - CVS Health (CVS) said that its Caremark unit will remove AbbVie’s (ABBV) blockbuster drug Humira from its major national commercial formularies on April 1 and c
0
sa:-3078159216903274425
0
https://www.zacks.com/stock/news/2203894/cvs-health-cvs-stock-moves-0-01-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2203894
Dec 29, 2023 - CVS Health (CVS) closed the most recent trading day at $78.96, moving -0.01% from the previous trading session.
zc:947613590766447753
0
https://www.zacks.com/stock/news/2202694/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202694
Dec 27, 2023 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
zc:5697746230444580253
0
https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html
Dec 22, 2023 - The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024.
0
cnbc:-1931917197999084157
0
https://www.zacks.com/stock/news/2201251/cvs-health-cvs-surpasses-market-returns-some-facts-worth-knowing?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2201251
Dec 21, 2023 - In the closing of the recent trading day, CVS Health (CVS) stood at $78.62, denoting a +1.79% change from the preceding trading day.
zc:-1921012559163352385
0